BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27378692)

  • 1. A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development.
    Bashamboo A; Donohoue PA; Vilain E; Rojo S; Calvel P; Seneviratne SN; Buonocore F; Barseghyan H; Bingham N; Rosenfeld JA; Mulukutla SN; Jain M; Burrage L; Dhar S; Balasubramanyam A; Lee B; ; Dumargne MC; Eozenou C; Suntharalingham JP; de Silva K; Lin L; Bignon-Topalovic J; Poulat F; Lagos CF; McElreavey K; Achermann JC
    Hum Mol Genet; 2016 Aug; 25(16):3446-3453. PubMed ID: 27378692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.
    Domenice S; Machado AZ; Ferreira FM; Ferraz-de-Souza B; Lerario AM; Lin L; Nishi MY; Gomes NL; da Silva TE; Silva RB; Correa RV; Montenegro LR; Narciso A; Costa EM; Achermann JC; Mendonca BB
    Birth Defects Res C Embryo Today; 2016 Dec; 108(4):309-320. PubMed ID: 28033660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development.
    Baetens D; Stoop H; Peelman F; Todeschini AL; Rosseel T; Coppieters F; Veitia RA; Looijenga LH; De Baere E; Cools M
    Genet Med; 2017 Apr; 19(4):367-376. PubMed ID: 27490115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR5A1 gene variants repress the ovarian-specific WNT signaling pathway in 46,XX disorders of sex development patients.
    Knarston IM; Robevska G; van den Bergen JA; Eggers S; Croft B; Yates J; Hersmus R; Looijenga LHJ; Cameron FJ; Monhike K; Ayers KL; Sinclair AH
    Hum Mutat; 2019 Feb; 40(2):207-216. PubMed ID: 30350900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical NR5A1 Missense Mutations in Two Unrelated 46,XX Individuals with Testicular Tissues.
    Igarashi M; Takasawa K; Hakoda A; Kanno J; Takada S; Miyado M; Baba T; Morohashi KI; Tajima T; Hata K; Nakabayashi K; Matsubara Y; Sekido R; Ogata T; Kashimada K; Fukami M
    Hum Mutat; 2017 Jan; 38(1):39-42. PubMed ID: 27610946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.
    Harrison SM; Campbell IM; Keays M; Granberg CF; Villanueva C; Tannin G; Zinn AR; Castrillon DH; Shaw CA; Stankiewicz P; Baker LA
    Am J Med Genet A; 2013 Oct; 161A(10):2487-94. PubMed ID: 23918653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 46,XX Ovotesticular Disorder of Sex Development Likely Caused by a Steroidogenic Factor-1 (NR5A1) Variant.
    Swartz JM; Ciarlo R; Guo MH; Abrha A; Weaver B; Diamond DA; Chan YM; Hirschhorn JN
    Horm Res Paediatr; 2017; 87(3):191-195. PubMed ID: 27855412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update--steroidogenic factor 1 (SF-1, NR5A1).
    Köhler B; Achermann JC
    Minerva Endocrinol; 2010 Jun; 35(2):73-86. PubMed ID: 20595937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in NR5A1 associated with ovarian insufficiency.
    Lourenço D; Brauner R; Lin L; De Perdigo A; Weryha G; Muresan M; Boudjenah R; Guerra-Junior G; Maciel-Guerra AT; Achermann JC; McElreavey K; Bashamboo A
    N Engl J Med; 2009 Mar; 360(12):1200-10. PubMed ID: 19246354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of the multiplex ligation-dependent probe amplification in the identification of a novel two-exon deletion of the NR5A1 gene in a patient with 46,XY differences of sex development.
    Nagy O; Kárteszi J; Hartwig M; Bertalan R; Jávorszky E; Erhardt É; Patócs A; Tornóczky T; Balogh I; Ujfalusi A
    Mol Biol Rep; 2019 Oct; 46(5):5595-5601. PubMed ID: 31338750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Follow-Up from Infancy to Puberty in a Japanese Male with SRY-Negative 46,XX Testicular Disorder of Sex Development Carrying a p.Arg92Trp Mutation in NR5A1.
    Saito-Hakoda A; Kanno J; Suzuki D; Kawashima S; Kamimura M; Hirano K; Sakai K; Igarashi M; Fukami M; Fujiwara I
    Sex Dev; 2019; 13(2):60-66. PubMed ID: 30739115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.
    Fabbri HC; de Andrade JG; Soardi FC; de Calais FL; Petroli RJ; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
    BMC Med Genet; 2014 Jan; 15():7. PubMed ID: 24405868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46,XY subjects and low ovarian reserve in fertile 46,XX subjects.
    Warman DM; Costanzo M; Marino R; Berensztein E; Galeano J; Ramirez PC; Saraco N; Baquedano MS; Ciaccio M; Guercio G; Chaler E; Maceiras M; Lazzatti JM; Bailez M; Rivarola MA; Belgorosky A
    Horm Res Paediatr; 2011; 75(1):70-7. PubMed ID: 20861607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A missense mutation in NR5A1 causing female to male sex reversal: A case report.
    Askari M; Rastari M; Seresht-Ahmadi M; McElreavey K; Bashamboo A; Razzaghy-Azar M; Totonchi M
    Andrologia; 2020 Jul; 52(6):e13585. PubMed ID: 32271476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testis formation in XX individuals resulting from novel pathogenic variants in Wilms' tumor 1 (
    Eozenou C; Gonen N; Touzon MS; Jorgensen A; Yatsenko SA; Fusee L; Kamel AK; Gellen B; Guercio G; Singh P; Witchel S; Berman AJ; Mainpal R; Totonchi M; Mohseni Meybodi A; Askari M; Merel-Chali T; Bignon-Topalovic J; Migale R; Costanzo M; Marino R; Ramirez P; Perez Garrido N; Berensztein E; Mekkawy MK; Schimenti JC; Bertalan R; Mazen I; McElreavey K; Belgorosky A; Lovell-Badge R; Rajkovic A; Bashamboo A
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13680-13688. PubMed ID: 32493750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are NR5A1 Variations a Frequent Cause of 46,XX Ovotesticular Disorders of Sex Development? Analysis from a Single Center and Systematic Review.
    Barros BA; Guaragna MS; Fabbri-Scallet H; Palandi de Mello M; Guerra-Júnior G; Maciel-Guerra AT
    Sex Dev; 2022; 16(4):242-251. PubMed ID: 36657429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals.
    Camats N; Pandey AV; Fernández-Cancio M; Andaluz P; Janner M; Torán N; Moreno F; Bereket A; Akcay T; García-García E; Muñoz MT; Gracia R; Nistal M; Castaño L; Mullis PE; Carrascosa A; Audí L; Flück CE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1294-306. PubMed ID: 22549935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal hormonal evaluation in a patient with disorder of sexual development, 46,XY karyotype and one NR5A1 mutation.
    Pedace L; Laino L; Preziosi N; Valentini MS; Scommegna S; Rapone AM; Guarino N; Boscherini B; De Bernardo C; Marrocco G; Majore S; Grammatico P
    Am J Med Genet A; 2014 Nov; 164A(11):2938-46. PubMed ID: 25160005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and/or depression.
    Suwanai AS; Ishii T; Haruna H; Yamataka A; Narumi S; Fukuzawa R; Ogata T; Hasegawa T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):957-65. PubMed ID: 23095176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel NR5A1 Pathogenic Variants Cause Phenotypic Heterogeneity in 46,XY Disorders of Sex Development.
    Sudhakar DVS; Jaishankar S; Regur P; Kumar U; Singh R; Kabilan U; Namduri S; Dhyani J; Gupta NJ; Chakravarthy B; Vaman K; Shabir I; Khadgawat R; Deenadayal M; Chaitanya A D; Dada R; Sharma Y; Anand A; Thangaraj K
    Sex Dev; 2019; 13(4):178-186. PubMed ID: 32008008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.